Meta-Analysis
Copyright ©The Author(s) 2024.
World J Diabetes. Jul 15, 2024; 15(7): 1615-1626
Published online Jul 15, 2024. doi: 10.4239/wjd.v15.i7.1615
Figure 4
Figure 4 Forest plot for positive outcomes. A: Reduction in insulin use; B: Change in C-peptide response; C: Change in glycated haemoglobin A1c level in Teplizumab versus control group. HbA1c: Glycated haemoglobin A1c; df: Degree of freedom; M-H: Mantel-Haenszel.